June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

January 2, 2015January 2, 2015

Studies Find Molecular Pathways Involved in Melanoma Drug Resistance

News

Two new studies entitled “Systematic identification of signaling pathways with potential to confer anticancer drug resistance” and “RAS signaling promotes resistance to JAK inhibitors by suppressing BAD-mediated apoptosis” identified new ... Read more

December 30, 2014December 30, 2014

Nivolumab Granted Accelerated Approval By The FDA

News

The U. S. Food and Drug Administration (FDA) recently granted accelerated approval to nivolumab (commercialized as OPDIVO by the Bristol-Myers Squibb Company) for the treatment of patients with unresectable or metastatic ... Read more

December 29, 2014December 29, 2014

Moderate Sun Exposure Boosts Vitamin D, Not Skin Cancer Risk, Experts Say

News

Nonprofit public health research organization, GrassrootsHealth (GRH), recently released a video featuring some of the most prominent experts on vitamin D, and their professional opinions and recommendations about “The Sunshine ... Read more

December 26, 2014December 26, 2014

Researchers Identify Protein Involved In Melanoma Metastasis Into The Lung

News

In a recent study titled “Role of Chitinase 3-like-1 and Semaphorin 7A in Pulmonary Melanoma Metastasis”, published in Cancer Research, a team of researchers from Brown and Yale University found ... Read more

December 23, 2014December 23, 2014

IBM Developing Intelligent Skin Lesion Analysis Diagnostic Technology

News

Multinational technology and consulting corporation, International Business Machines Corporation (IBM), has partnered with Memorial Sloan Kettering to explore the potential application of cognitive computing in examining images of skin lesions, in the hope ... Read more

December 22, 2014December 22, 2014

Airline Pilots Are Exposed To High Levels of UV-A Cockpit Radiation

News

A group of researchers from the University of California published a recent research letter in JAMA Dermatology whereby they state airline pilots could be exposed to the same levels of ... Read more

December 19, 2014December 19, 2014

Scientists Can Reprogram Skin Fibroblasts Into Melanocytes

News

A new study established a way to convert fibroblasts into functional melanocytes, the body’s pigment-producing cells. The study entitled “Direct conversion of mouse and human fibroblasts to functional melanocytes by ... Read more

December 18, 2014December 18, 2014

New Drugs To Treat Drug Resistant Melanoma Discovered by Researchers

News

In a recent study published in the journal Cancer Cell scientists at The Institute of Cancer Research, London, and the Cancer Research UK Manchester Institute, found a new family of drugs, ... Read more

December 17, 2014December 17, 2014

Study Finds Hair Shaft miRNA-221 Levels Can Be Used As Malignant Melanoma Biomarker

News

In a recent study titled “Hair shaft miRNA-221 levels as a new tumor marker of malignant melanoma”, published in The Journal of Dermatology, a team of researchers from Kumamoto University, Japan, ... Read more

December 16, 2014December 16, 2014

Study Evaluates Number of Nevi Biopsies in U.S. Children

News

In a recent research letter titled “Biopsies of Nevi in Children and Adolescents in the United States, 2009 Through 2013”, published in Jama Dermatology, a group of scientists led by ... Read more

December 15, 2014December 15, 2014

Study Finds Firefighters Have Increased Risk of Melanoma

News

A study led by Monash University researchers found that firefighters have an increased risk of developing melanoma and prostate cancer when compared to the general public. The analysis, appointed by ... Read more

December 12, 2014December 12, 2014

ImmunID To Begin PREDICT-ID Clinical Trial in Metastatic Melanoma Patients

News

A new study called PREDICT-ID Melanoma is going to assess the predictive value of immune profiles for response to the drug agent ipilimumab. The company that developed this agent, ImmunID, ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group